These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24623235)

  • 1. Quantifying in vivo somatic mutations using transgenic mouse model systems.
    Swiger RR
    Methods Mol Biol; 2014; 1105():271-82. PubMed ID: 24623235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying in vivo somatic mutations using transgenic mouse model systems.
    Swiger RR
    Methods Mol Biol; 2005; 291():145-53. PubMed ID: 15502219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo cII, gpt, and Spi⁻ gene mutation assays in transgenic mice and rats.
    Manjanatha MG; Cao X; Shelton SD; Mittelstaedt RA; Heflich RH
    Methods Mol Biol; 2013; 1044():97-119. PubMed ID: 23896873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
    Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
    Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
    Zimmer DM; Harbach PR; Mattes WB; Aaron CS
    Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Just how does the cII selection system work in Muta Mouse?
    Swiger RR
    Environ Mol Mutagen; 2001; 37(4):290-6. PubMed ID: 11424178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new transgenic mouse mutagenesis test system using Spi- and 6-thioguanine selections.
    Nohmi T; Katoh M; Suzuki H; Matsui M; Yamada M; Watanabe M; Suzuki M; Horiya N; Ueda O; Shibuya T; Ikeda H; Sofuni T
    Environ Mol Mutagen; 1996; 28(4):465-70. PubMed ID: 8991079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cII locus in the MutaMouse system.
    Swiger RR; Cosentino L; Shima N; Bielas JH; Cruz-Munoz W; Heddle JA
    Environ Mol Mutagen; 1999; 34(2-3):201-7. PubMed ID: 10529745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High sensitivity for color mutants in lacZ plasmid-based transgenic mice, as detected by positive selection.
    Boerrigter ME
    Environ Mol Mutagen; 1998; 32(2):148-54. PubMed ID: 9776177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel Escherichia coli-derived mutation detected with the Big Blue cII mutant selectable assay.
    Ward TL; Prtenjaca A; Hill KA
    Environ Mol Mutagen; 2010 May; 51(4):344-8. PubMed ID: 20120017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and spectrum of ENU-induced mutation in the Phi X174 transgene in mouse splenic lymphocytes and their significance to spontaneous transgenic rodent mutation frequencies.
    Valentine CR; Rainey HF; Farrell JM; Shaddock JG; Dobrovolsky VN; Delongchamp RR
    Mutagenesis; 2008 Sep; 23(5):383-97. PubMed ID: 18504270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of O (6)-alkylguanine-DNA alkyltransferase deficiency in Escherichia coli as the host for the detection of mutations in lacI transgenic mice.
    Sui H; Suzuki M; Yamada M; Hara T; Kawakami K; Shibuya T; Nohmi T; Sofuni T
    Environ Mol Mutagen; 1999; 34(2-3):221-6. PubMed ID: 10529748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative dose-response analysis of ethyl methanesulfonate genotoxicity in adult gpt-delta transgenic mice.
    Cao X; Mittelstaedt RA; Pearce MG; Allen BC; Soeteman-Hernández LG; Johnson GE; Bigger CA; Heflich RH
    Environ Mol Mutagen; 2014 Jun; 55(5):385-99. PubMed ID: 24535894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of Muta™Mouse λgt10-lacZ transgene: evidence for in vivo rearrangements.
    Shwed PS; Crosthwait J; Douglas GR; Seligy VL
    Mutagenesis; 2010 Nov; 25(6):609-16. PubMed ID: 20724577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo mutation analysis using the ΦX174 transgenic mouse and comparisons with other transgenes and endogenous genes.
    Valentine CR; Delongchamp RR; Pearce MG; Rainey HF; Dobrovolsky VN; Malling HV; Heflich RH
    Mutat Res; 2010 Dec; 705(3):205-16. PubMed ID: 20637298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target.
    Jakubczak JL; Merlino G; French JE; Muller WJ; Paul B; Adhya S; Garges S
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9073-8. PubMed ID: 8799156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of mitomycin C-induced large deletions and tandem-base substitutions in the bone marrow of gpt delta transgenic mice.
    Takeiri A; Mishima M; Tanaka K; Shioda A; Ueda O; Suzuki H; Inoue M; Masumura K; Nohmi T
    Chem Res Toxicol; 2003 Feb; 16(2):171-9. PubMed ID: 12588188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue male mice.
    Barnett LB; Tyl RW; Shane BS; Shelby MD; Lewis SE
    Environ Mol Mutagen; 2002; 40(4):251-7. PubMed ID: 12489115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice.
    Walker VE; Gorelick NJ; Andrews JL; Craft TR; deBoer JG; Glickman BW; Skopek TR
    Cancer Res; 1996 Oct; 56(20):4654-61. PubMed ID: 8840980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.